Homeopathic Drugmaker Puts Up $1M To End False Ad Claims – Law360. *Paywalled article
Homeopathic treatment manufacturer Heel Inc. agreed Wednesday to dial down its health claims tied to its over-the-counter remedies and pay a $1 million class settlement to resolve accusations that it exaggerated the products’ effectiveness to consumers.
The Heel company will refund up to $150 per buyer for those that request it. They also agreed to add disclaimers clarifying the scientific underpinnings of its marketing of drugs. Gee, I wonder what that will look like.
According to their wikipedia page, they have a long-running problem with labeling their products. Previously known as BHI, in 1984 they were warned by the FDA that they were in violation of federal regulations with regards to marketing their remedies.
BHI was given multiple FDA citations and fines during the 1980s and early 1990s for violation of the Compliance Policy Guidelines labelling guidelines established by the FDA in 1988.
I found another interesting thing about Heel, a German-based company. They were one of the group of German companies that paid a journalist to smear scientists who were speaking out against homeopathy.
Their revenue in 2011 was $251 million. So, this settlement is small potatoes.